541304 — Indo US Bio-Tech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Indo US Bio-Tech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.822	2	1.32	0.492	1.9
Net Total Accounts Receivable
Net Total Receivables	103	225	261	234	328
Total Inventory
Total Other Current Assets
Total Current Assets	212	319	381	468	599
Net Property, Plant And Equipment	25.4	26.8	43.2	78.8	87.3
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	239	347	437	556	695
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	86.8	170	180	123	123
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	99.6	183	221	171	150
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	139	164	215	385	545
Total Liabilities & Shareholders' Equity	239	347	437	556	695
Total Common Shares Outstanding